1. Home
  2. /
  3. Projects

https://tbvaccinesforum.org/rio-de-janeiro/2024-posters/

New tuberculosis vaccines are in late-stage trials, but how confident is the public in high burden countries in vaccines?

Ongoing
With tuberculosis (TB) vaccine candidates in late-stage trials, it is important to prepare for implementation to avoid delays upon licensure. General confidence in vaccines has been identified as an anticipated barrier to introducing new TB vaccines. In the absence of detailed TB specific vaccine acceptability and confidence data, we analysed currently available vaccine confidence data in countries appearing on one of the World Health Organization (WHO) high burden lists to investigate vaccine confidence in countries with a high TB burden

Preparing the landscape for TB vaccines: South Africa’s strategic planning

Ongoing
The South African TB Think Tank is a national collaboration of TB stakeholders, including researchers, policymakers, clinicians, and civil society. Chaired by the Chief Director of the National TB Programme (NTP), members consolidate TB research through several technical task teams, providing evidenced-based policy recommendations to the Department of Health. To support the national TB vaccine initiative, the TB Think Tank provided recommendations for the recently released NTP Strategic Plan, 2023-28

Forecasting TB vaccine demand to support supply and procurement planning

Ongoing
We present insights from two workshops with global health funders, academics, and in country TB and vaccine decision-makers and estimates of potential global demand for TB vaccines using a bottom-up, constrained demand forecasting model. The model was informed by the workshops, publicly available target product profile, landscape assessment of vaccines in development, information from proxy vaccines sourced from the WHO databases and peer reviewed literature, and interviews with TB and vaccine experts

Financing and policy innovation to advance TB vaccines through licensure: A G20 policy proposal

Ongoing
The authors developed two T20 policy briefs proposing recommendations to enhance G20 leadership and bring TB vaccines through licensure: Investment Toolbox to Advance TB Vaccine R&D through Joint Action (2023); and Elevating Leadership of HBC G20 States in TB Vaccine R&D and Delivery (2024). The briefs were informed by extensive literature research and aligned with global initiatives for TB and TB vaccine R&D.

Potential implications of reduced tuberculosis vaccine efficacy in those with undernutrition on overall vaccine impact in India

Hypothetical vaccine
Ongoing
Nutritional status is a leading risk factor for tuberculosis (TB). In India up to half of all TB episodes are attributed to undernutrition. Given the impact of nutrition on the immune system, vaccine characteristics such as efficacy and duration of protection could vary depending on nutritional status. Therefore, previous vaccine impact estimates may be overestimated. We re estimated vaccine impact in India with reduced efficacy with undernutrition
Load More
Click to copy link of this header Menu